About
Technology
Issues
FAQ
Links
Official Page
Renovascular hypertension from the BCR‐ABL tyrosine kinase inhibitor ponatinib
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.